Related Experiment Video
Updated: Jul 8, 2025

10:21
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.6K
NG-DTA: Drug-target affinity prediction with n-gram molecular graphs
Summary
This study introduces N-gram Graph DTA (NG-DTA), a deep learning model for drug-target affinity prediction. NG-DTA improves accuracy by representing proteins as n-gram molecular sub-graphs, outperforming existing methods.
Area of Science:
- Computational chemistry
- Bioinformatics
- Drug discovery
Background:
- Drug-target affinity (DTA) prediction is vital for accelerating drug development.
- Current deep learning models often represent proteins as 1D strings, limiting their informative capacity compared to graph representations.
- Graph neural networks (GNNs) offer a more powerful approach for molecular data analysis.
Purpose of the Study:
- To develop an advanced deep learning method for accurate DTA prediction.
- To investigate the impact of protein molecular sub-graph representation on DTA prediction performance.
- To establish a novel computational tool for drug discovery pipelines.
Main Methods:
- Developed N-gram Graph DTA (NG-DTA), a deep learning model utilizing GNNs.
- Input features include molecular graphs of drugs and n-gram molecular sub-graphs of proteins.
- No protein structure prediction tools were employed.
Main Results:
- NG-DTA achieved superior performance on both Davis and Kiba datasets.
- Achieved a concordance index (CI) of 0.905 and mean square error (MSE) of 0.196 on the Davis dataset.
- Achieved a CI of 0.904 and MSE of 0.120 on the Kiba dataset.
- Demonstrated that n-gram protein sub-graphs enhance deep learning model performance for DTA prediction.
Conclusions:
- Representing proteins using n-gram molecular sub-graphs significantly improves deep learning-based DTA prediction.
- NG-DTA offers a promising and effective approach for computational drug discovery.
- The method provides accurate DTA predictions without relying on protein structure prediction.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design
728
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
728
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K

